215 cardiovascular disease drugs in the pipeline, report finds

06/13/2013 | Drug Store News · PharmaTimes (U.K.)

A total of 215 drugs for heart disease and stroke are awaiting FDA approval or are in clinical trials, according to a report from the Pharmaceutical Research and Manufacturers of America. The lineup includes 30 for heart failure, 29 for lipid disorders, 19 for stroke and 17 for hypertension.

View Full Article in:

Drug Store News · PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA